[28 September 2018] The IBTA’s monthly e-News has now been released and has been emailed to all subscribers. To sign up to receive your copy, click here.
You can read the IBTA e-News September 2018 edition in full online here.
Some of the highlights from this month’s round-up:
- The IBTA-initiated International Brain Tumour Awareness Week is fast approaching and will be running from 20-27th October 2018. It is a fantastic opportunity for anyone in the international brain tumour community to organise and/or take part in awareness-raising activities to highlight the various issues surrounding brain tumour treatment, care and support. Contact the IBTA at kathy@theibta.org if you have any questions about setting up an awareness-raising activity.
- A report published in the journal Clinical Trials and a systematic review in The Lancet Oncology have established the pressing need for improved consistency and standardisation in measuring patient-recorded outcomes (such as quality of life assessments) in cancer clinical trials. The IBTA’s Chair, Kathy Oliver, is one of the co-authors of these two papers
- Researchers have successfully engineered T-cells (a type of immune cell) that will pass through the blood-brain barrier and also target glioblastoma tumour cells, leading to tumour destruction, according to the findings of a paper published in Nature.
- The Children’s Brain Tumor Tissue Consortium (CBTTC) has announced the launch of the free-to-access Pediatric Brain Tumor Atlas, a dataset of more than 2,500 childhood brain tumour samples.
- In patients with newly diagnosed glioblastoma, the experimental drug iniparib with concurrent radiotherapy and temozolomide has shown anticancer activity and an encouraging safety profile, according to phase 2 clinical trial findings.
- A study published in the International Journal of Cancer has found significant differences in the genetic risk factor associated with glioblastoma between young and old patients. Such age-specific differences may provide important clues to the origin of these tumours.
- September has seen the launch of the ‘Less Survivable Cancers Taskforce’ campaign to double the five-year survival of brain tumours, and lung, liver, stomach, pancreatic and oesophageal cancers in England.
Our monthly e-News highlights items of interest to our international brain tumour community and is emailed to nearly 6,000 recipients. It gives a round-up of the latest research and treatment developments, news about brain tumour patient organisations around the world, and key forthcoming neuro-oncology scientific and patient conferences. You can sign up to receive the e-News every month by registering here.
To see an archive of existing e-News issues, click here.
